Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Pamela J. Atherton"'
Autor:
Aref Al‐Kali, Ibrahim Aldoss, Pamela J. Atherton, Carrie A. Strand, Bijal Shah, Jonathan Webster, Bhavana Bhatnagar, Karen S. Flatten, Kevin L. Peterson, Paula A. Schneider, Sarah A. Buhrow, Jianping Kong, Joel M. Reid, Alex A. Adjei, Scott H. Kaufmann
Publikováno v:
Cancer Medicine, Vol 12, Iss 23, Pp 21229-21239 (2023)
Abstract Background Despite recent approval of several new agents, relapsed acute lymphoblastic leukemia (ALL) remains challenging to treat. Sapanisertib (MLN0128/TAK‐228) is an oral TORC1/2 inhibitor that exhibited preclinical activity against ALL
Externí odkaz:
https://doaj.org/article/55ca42b54be149f0b8acb389ece68dc9
Autor:
Joshua R. Niska, Cameron S. Thorpe, Michele Y. Halyard, Angelina D. Tan, Pamela J. Atherton, Amylou C. Dueck, Samir H. Patel, Jeff A. Sloan
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-8 (2020)
Abstract Purpose To assess the relationship between patient-reported quality-of-life (QOL) outcomes and provider-assessed adverse events (AEs) during head-and-neck (H&N) radiotherapy (RT). Methods Sixty-five patients undergoing H&N RT prospectively c
Externí odkaz:
https://doaj.org/article/fe17b92377fe40aea639187030c0a1fd
Autor:
Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, Evanthia Galanis
Supplementary Figure 1 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e7b53394e88bb3443e51dd630338ca
https://doi.org/10.1158/0008-5472.22387359
https://doi.org/10.1158/0008-5472.22387359
Autor:
Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, Evanthia Galanis
Supplementary Figure 4 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::670186b4c98f91eaabf7e46e35fe7860
https://doi.org/10.1158/0008-5472.22387350.v1
https://doi.org/10.1158/0008-5472.22387350.v1
Autor:
Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, Evanthia Galanis
Supplementary Figure 2 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2c6bfed5fa15d017a043422031d991
https://doi.org/10.1158/0008-5472.22387356
https://doi.org/10.1158/0008-5472.22387356
Autor:
Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, Evanthia Galanis
Supplementary Figure Legends 1-5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eba29566c87f3177615e7af116688ab
https://doi.org/10.1158/0008-5472.22387344.v1
https://doi.org/10.1158/0008-5472.22387344.v1
Autor:
Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, Evanthia Galanis
Supplementary Figure 5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::189ef8edb0c43644ba9b3406b3c6443e
https://doi.org/10.1158/0008-5472.22387347
https://doi.org/10.1158/0008-5472.22387347
Autor:
Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, Evanthia Galanis
Supplementary Figure 3 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a70e94350356f395df05fe9c8d4e18
https://doi.org/10.1158/0008-5472.22387353
https://doi.org/10.1158/0008-5472.22387353
Autor:
Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, Evanthia Galanis
Supplementary Table 1 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20bb3dd657f12578b58a2def56521b60
https://doi.org/10.1158/0008-5472.22387341.v1
https://doi.org/10.1158/0008-5472.22387341.v1
Autor:
Jamal Misleh, Olwen Hahn, Dean F. Bajorin, Karla A Ballman, Joel Picus, Michael J. Morris, Scott T. Tagawa, Walter M. Stadler, Susan Halabi, Jonathan E. Rosenberg, Benjamin A. Teply, Christopher Sweeney, Daniel A. Vaena, Robert Dreicer, Eric J. Small, Christopher J. Hoimes, Sreedhar Katragadda, Elizabeth R. Plimack, Pamela J. Atherton, Thomas W. Flaig, Amir Mortazavi
Publikováno v:
J Clin Oncol
PURPOSE The combination of gemcitabine and cisplatin (GC) is a standard therapy for metastatic urothelial carcinoma. Based on data that angiogenesis plays a role in urothelial carcinoma growth and progression, a randomized placebo-controlled trial wa